Esperion Therapeutics | 现金及等价物



金融业
股票价格
USD
资产
USD 364.02M
现金及等价物
USD 92.45M
销售成本
USD 51.63M
流动资产
USD 360.46M
流动负债
USD 359.03M
债务
USD 262.92M
股息收益率
0
EBIT
USD -16.03M
EBITDA
USD -27.51M
员工
240
EPS每股收益
USD -0.15
股本和储备
USD -451.36M
销售毛利
USD -29.52M
债务利息支出
USD 15.08M
利息收入
USD -0.15
贷款资金
USD 262.48M
市值
USD 613.4M
净收入
USD -29.52M
营业费用
USD 67.66M
营业利润
USD -16.03M
普通股股本
USD 112K
PE价格收益
129.79
税前利润
USD 67.66M
销售收入
USD 51.63M
销售和管理费用
USD 39.98M
股票
USD 108.54M
贸易债权人
USD 77.51M
应收帐款人
USD 60.36M


现金及等价物 更改 日
AbbVie USD 5.23B 400M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Cipla INR 7.96B 39.9M 2025-09
CSL USD 2.16B 633M 2025-06
Cytokinetics USD 122.52M 102.95M 2025-12
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Geron USD 79.44M 553K 2025-12
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Merck USD 18.17B 10.16B 2025-09
Minerva Neurosciences USD 12.29M 2.96M 2025-09
Moderna USD 2.6B 1.46B 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 984.65M 312.03M 2025-12
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
United Therapeutics USD 1.56B 217M 2025-12
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12


Esperion Therapeutics 现金及等价物 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.